TaiMed Biologics Inc. (TPEX:4147)

TaiMed Biologics Revenue

TaiMed Biologics had revenue of 137.54M TWD in the quarter ending June 30, 2025, a decrease of -6.40%. This brings the company's revenue in the last twelve months to 598.06M, down -6.79% year-over-year. In the year 2024, TaiMed Biologics had annual revenue of 610.16M with 24.07% growth.

• Revenue (ttm): 598.06M
• Revenue Growth: -6.79%
• P/S Ratio: 32.62
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 19.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	610.16M	118.39M	24.07%
Dec 31, 2023	491.78M	-71.23M	-12.65%
Dec 31, 2022	563.01M	149.57M	36.18%
Dec 31, 2021	413.44M	-309.04M	-42.78%
Dec 31, 2020	722.49M	17.98M	2.55%